Cancer Drug Development: Changing the Paradigm, Washington, DC, USA
Event Sep 26
Evaluate FDA's "Critical Path Initiative." Implement dose selection, animal to human scaling, modeling/simulation, biomarkers/biomarker validation strategies. Comply with pharmacogenomics/proteomics, adaptive study design, data management/analysis requirements. Commercialize oncology agents through practical examples.
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018